MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$53,965K
EPS
-$0.81
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
44,437
42,123
32,483*
41,968
General and administrative expense
12,817
11,574
13,365*
13,627
Total operating expenses
57,254
53,697
45,848
55,595
Loss from operations
-57,254
-53,697
-45,848*
-55,595
Interest income
3,648
4,098
6,933*
5,093
Other expense, net
-98
-62
-119*
-108
Net loss before income taxes
-
-
-39,034*
-
Effective tax rate
-
-
0*
-
Total other income
3,550
-
-
-
Net loss
-53,704
-49,661
-39,034*
-50,610
Net loss attributable to noncontrolling interests
-
-
0*
0
Unrealized gain (loss) on investments
-261
-
-
-
Net loss attributable to cullinan
-
-
-39,034
-50,610
Net loss
-
-45,485
-
-
Comprehensive loss
-53,965
-
-
-
Basic EPS
-0.81
-0.75
-0.661
-0.77
Diluted EPS
-0.81
-0.75
-0.661
-0.77
Basic Average Shares
61,493,000
60,462,000
59,025,000
59,075,000
Diluted Average Shares
61,493,000
60,462,000
59,025,000
59,075,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
CGEM Income Statement Sankey Diagram
Sankey diagram visualizing CGEM income statement for the period
Comprehensive loss
-$53,965K
(22.86%↑ Y/Y)
Interest income
$3,648K
Net loss
-$53,704K
(23.34%↑ Y/Y)
Unrealized gain (loss) on
investments
-$261K
(-355.88%↓ Y/Y)
Total other income
$3,550K
Other expense, net
-$98K
Loss from operations
-$57,254K
Total operating
expenses
$57,254K
Research and development
$44,437K
General and
administrative expense
$12,817K
Buy us a coffee
Cullinan Therapeutics, Inc. (CGEM)
Cullinan Therapeutics, Inc. (CGEM)